Viewing Study NCT05797233

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-06-23 @ 8:38 PM
Study NCT ID: NCT05797233
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-19
First Post: 2023-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None B-Cell Chronic Lymphocytic Leukemia View
None Lymphoma, B-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Autologous T Cells Infusion View
None Hu1928-Hu20BB View
None Adoptive T Cell Therapy View
None Gene Therapy View